Anti-interferon-α antibodies and HBsAg seroclearance during peginterferon-α therapy in chronic hepatitis B
Aims/Background: To identify predictors of hepatitis B surface antigen (HBsAg) seroclearance in chronic hepatitis B (CHB) patients treated with Peginterferon-α (Peg-IFNα) and to assess the association between anti-interferon-α (anti-IFNα) antibody development and treatment outcomes. Methods: CHB pat...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Elsevier
2026-03-01
|
| Ráidu: | International Journal of Infectious Diseases |
| Fáttát: | |
| Liŋkkat: | http://www.sciencedirect.com/science/article/pii/S1201971226000056 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|